Van Plew Daniel P 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Van Plew Daniel P
SVP & GM, Indust Ops&Prod Supp
Transactions
- Sale
Common Stock
2024-02-14$947.81/sh−240$227,474→ 21,215 total - Sale
Common Stock
2024-02-14$945.81/sh−95$89,852→ 21,455 total - Sale
Common Stock
2024-02-14$939.60/sh−750$704,700→ 29,397 total - Sale
Common Stock
2024-02-14$943.51/sh−2,691$2,538,985→ 22,170 total - Sale
Common Stock
2024-02-14$950.45/sh−375$356,419→ 20,578 total - Sale
Common Stock
2024-02-14$941.41/sh−275$258,888→ 24,861 total - Sale
Common Stock
2024-02-14$937.94/sh−439$411,756→ 30,373 total - Sale
Common Stock
2024-02-14$938.13/sh−226$212,017→ 30,147 total - Sale
Common Stock
2024-02-14$940.44/sh−4,261$4,007,215→ 25,136 total - Sale
Common Stock
2024-02-14$944.30/sh−620$585,466→ 21,550 total - Sale
Common Stock
2024-02-14$948.70/sh−150$142,305→ 21,065 total - Sale
Common Stock
2024-02-14$949.07/sh−112$106,296→ 20,953 total - Sale
Common Stock
2024-02-14$951.77/sh−200$190,354→ 20,378 total
Holdings
- 1,084(indirect: By 401(k))
Common Stock
- 12,376(indirect: 2023 GRAT)
Common Stock
Footnotes (13)
- [F1]Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F10]Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F11]Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F12]Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F13]Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.